Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
Volume 0.52M
Average 0.39M
SION Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Sionna Therapeutics, Inc.NASDAQ: SION
Short-term Investments · Q1 FY2026 · quarter ended Mar 2026
Short-term investments falls 18.3% from a year ago
Short-term investments stood at $152.83M at the end of Q1 FY2026, down 18.3% from a year earlier and down 13.9% from the prior quarter. Over 3 fiscal years it compounded at +85.6% a year.
Context
- Short-term investments amounted to 50.1% of total assets at the end of Q1 FY2026, down 0.5 pp from a year earlier.
- Short-term investments increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether short-term investments keeps falling in the next quarterly balance sheet after a -18.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 177.43M USD
- Year-over-year change
- +61.7%
- 3-year CAGR
- +85.6%
| Period | Period end | Short-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 177.43M | +61.7% |
| FY2024 | 2024-12-31 | 109.75M | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 27.77M | — |
Short-term Investments vs competitors
How SION compares with its peers on the latest reported figures
- SION's Mar 2026 short-term investments of $152.83M is the 8th highest of the 11 companies compared; the peer median is $227.8M.
- Its year-over-year change of -18.3% is the 6th highest of 8, against a peer median of -3.8%.
- Short-term investments amounts to 50.1% of total assets for SION, versus a peer median of 40.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $904.56M | -3.8% | +49.1% | 88.0% | |
| Sep 2026 | $623.37M | +13.9% | +21.1% | 86.4% | |
| Sep 2026 | $600.62M | +45.6% | -6.8% | 40.0% | |
| Jun 2026 | $450.29M | -11.3% | +71.6% | 84.5% | |
| Sep 2026 | $248.74M | — | — | 49.2% | |
| Mar 2026 | $206.87M | +13.0% | +92.0% | 41.0% | |
| Mar 2026 | $153.62M | — | — | 36.6% | |
| Mar 2026 | $152.83M | -18.3% | +85.6% | 50.1% | |
| Jun 2026 | $29.83M | -87.5% | -30.0% | 8.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | -100.0% | +27.1% | 0.0% | |
| Peer median (excluding SION) | $227.8M | -3.8% | +27.1% | 40.5% | |
Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Sionna Therapeutics, Inc.
NASDAQ:SION
Intrinsic Alpha fair value
Locked
Current Price
$2.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.